Searched for
RADIOPHARMACEUTICAL DRUGS
These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsAs far as India is concerned, the biggest pain point from the US-Iran war in the Gulf region has been the spike in the prices of not only o...
Aurobindo Pharma arm CuraTeQ gets Health Canada nod for biosimilarAurobindo Pharma announced a significant development today. Its subsidiary, CuraTeQ Biologics, has received a compliance notice from Health...
Drugmakers turn to AI to speed trials, regulatory submissionsAI is helping find participants and sites for clinical trials and drafting documents for regulators, shaving weeks off these labor-intensi...
Aurobindo Pharma’s Dyrupeg faces Health Canada compliance noticeCuraTeQ Biologics, a part of Aurobindo Pharma, has secured a crucial approval from Health Canada for its biosimilar drug Dyrupeg. This medi...
Volatility is temporary, fundamental tailwinds are permanent: 5 mid-cap pharma stocks with an upside potential of up to 46%Official Action Indicated (OAI). Not many investors may have heard of this. But they would surely have felt its impact. For, the moment OAI...
Volatile phases come and go, structural tailwinds are a stronger play: 5 Indian pharma stocks with upside potential of up to 35%There are some sectors which have witnessed something which can be called “second inning”. Which is that in the last two decades, they did ...
AstraZeneca to buy fusion for $2 billionThe deal gives AstraZeneca a foothold in the radiopharmaceutical drugs market, which has seen increasing investor interest since 2021 when ...
Jubilant Pharmova shares jump over 6% on receiving USFDA approval for Technetium Sulfur Colloid InjectionFor this approval, Jubilant is eligible for 180 days of exclusivity through the ‘Competitive Generic Therapy’ designation from the US FDA.
BRICS Nuclear medicine experts brainstorm in Moscow for future solutionsThe event was attended by the heads and leading scientists of the largest research medical centers, manufacturers of medical radioisotopes ...
Russian nuclear major Rosatom Increasing Isotope Supplies to IndiaThe Regional Alliance, Isotope JSC, is the official supplier of the isotope package from Rosatom Corporation to the international market an...
Jubilant Pharmova Q1 results: Co posts net profit of Rs 160 croreRevenue from continuing operations stood at Rs 1,634.65 crore in the quarter under review. It was Rs 1,156.07 crore in the same period a ye...
'Can treat tumors that you cannot see'. Radiation drugs hunt & kill cancer cells, says new studyThe drug in this case is a molecule that contains two parts: a tracker and a cancer-killing payload.
Stock pick of the week: Jubilant Life Sciences offers long-term growth say analystsSharp stock price correction, strong growth rates, focus on the growing speciality pharma segment, a bouquet of niche products, among other...
Jubilant Life Sciences plans Rs 550-cr capex in FY19Pharma company Jubilant Life Sciences is planning to invest Rs 300 crore in research and development (R&D) in FY19.
Jubilant Life Sciences announces price hike of up to 15%Jubilant Life Sciences is engaged in pharmaceuticals, life science ingredients and drug discovery solutions.
Jubilant Life plans to raise up to Rs 1,300 croreDrug firm Jubilant Life Sciences' board will meet on Thursday to consider a proposal to raise about Rs 1,300 crore through issuance of secu...
Jubilant to market Technegas in US; signs pact with CyclopharmJubilant Life Sciences said its subsidiary Jubilant DraxImage Inc has signed a term sheet with Cyclopharm for licence to market Technegas i...
- Jubilant Life Q4 net loss at Rs 31 crore
Jubilant Life Sciences said it has narrowed its consolidated net loss to Rs 30.97 cr for the fourth quarter ended March 31, 2013, mainly on...
- Budget 2012: Exempt all life saving medical devices from customs duty, says FICCI
FICCI in its pre-budget memorandum has given the following recommendations for the Medical Equipments and Devices industry
- Scientists develop cost-effective nuclear medicine kit
A new cost-effective nuclear medicine kit has been developed by Indian scientists to tackle growing number of infectious diseases in the co...